Clal Biotechnology Industries Ltd. Share Price
Equities
CBI
IL0011042806
Investment Holding Companies
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.5 ILa | +5.32% | +2.37% | +19.65% |
Sales 2022 | 370K 99.12K 37M 8.27M | Sales 2023 | 104K 27.86K 10.4M 2.32M | Capitalization | 62.27M 16.68M 6.23B 1.39B |
---|---|---|---|---|---|
Net income 2022 | -61M -16.34M -6.1B -1.36B | Net income 2023 | -31M -8.3M -3.1B -693M | EV / Sales 2022 | 331 x |
Net Debt 2022 | 23.85M 6.39M 2.38B 533M | Net Debt 2023 | 22.4M 6M 2.24B 501M | EV / Sales 2023 | 814 x |
P/E ratio 2022 |
-1.6
x | P/E ratio 2023 |
-2.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.65% |
1 day | +5.32% | ||
1 week | +2.37% | ||
Current month | +13.37% | ||
1 month | +13.37% | ||
3 months | +24.02% | ||
6 months | +7.22% | ||
Current year | +19.65% |
Managers | Title | Age | Since |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01/15/01 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 09/03/09 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18/15/18 |
Gad Keren
BRD | Director/Board Member | 73 | 17/20/17 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 47.5 | +5.32% | 142 229 |
25/24/25 | 45.1 | -2.80% | 16,816 |
24/24/24 | 46.4 | +3.57% | 17,970 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 30, 2024 at 07:54 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+19.65% | 18.83M | |
+16.98% | 76.16B | |
+59.45% | 17.61B | |
+2.74% | 15.94B | |
+8.60% | 14.05B | |
-0.04% | 12.4B | |
+8.96% | 12.06B | |
+5.82% | 10.89B | |
+34.35% | 10.34B | |
-1.92% | 9.75B |
- Stock Market
- Equities
- CBI Stock